A Study of Necitumumab in the First-Line Treatment of Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC)
Clinical trial NCT01763788 · COMPLETED
Trial details
- NCT number
- NCT01763788
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-07
- Primary completion
- 2017-06-28
- Enrollment
- 192
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.